Target Validation Information
Target ID T43739
Target Name Voltage-gated sodium channel subunit alpha Nav1.8
Target Type
Successful
Drug Potency against Target N-(2-chlorobenzyl)-5-(4-chlorophenyl)nicotinamide Drug Info IC50 = 81 nM [531169]
Tetracaine Drug Info IC50 = 700 nM [553280]
SCH-725737 Drug Info IC50 = 9000 nM [529019]
5-(4-chlorophenyl)-N-(2-methylbenzyl)nicotinamide Drug Info IC50 < 30 nM [531169]
N-benzyl-5-(4-chlorophenyl)nicotinamide Drug Info IC50 = 620 nM [531169]
1-[5-(4-Chlorophenyl)-2-furoyl]piperazine Drug Info IC50 = 2900 nM [529491]
References
Ref 531169Bioorg Med Chem Lett. 2010 Nov 15;20(22):6812-5. Epub 2010 Sep 18.Subtype-selective Na(v)1.8 sodium channel blockers: identification of potent, orally active nicotinamide derivatives.
Ref 553280Fundamental properties of local anesthetics: half-maximal blocking concentrations for tonic block of Na+ and K+ channels in peripheral nerve. Anesth Analg. 1998 Oct;87(4):885-9.
Ref 529019Bioorg Med Chem Lett. 2007 Oct 15;17(20):5543-7. Epub 2007 Aug 16.Novel steroidal saponins, Sch 725737 and Sch 725739, from a marine starfish, Novodinia antillensis.
Ref 531169Bioorg Med Chem Lett. 2010 Nov 15;20(22):6812-5. Epub 2010 Sep 18.Subtype-selective Na(v)1.8 sodium channel blockers: identification of potent, orally active nicotinamide derivatives.
Ref 531169Bioorg Med Chem Lett. 2010 Nov 15;20(22):6812-5. Epub 2010 Sep 18.Subtype-selective Na(v)1.8 sodium channel blockers: identification of potent, orally active nicotinamide derivatives.
Ref 529491Bioorg Med Chem. 2008 Jun 15;16(12):6379-86. Epub 2008 May 6.Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic pain.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.